Cancer chemotherapy alters plasma concentration of immunoreactive calcitonin. 1983

C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
April 1980, The Journal of clinical endocrinology and metabolism,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
January 1979, Endocrine research communications,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
June 1980, Metabolism: clinical and experimental,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
November 1974, Biochemical and biophysical research communications,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
December 1975, Pathologie-biologie,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
January 1987, Comparative biochemistry and physiology. A, Comparative physiology,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
April 1984, Tumori,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
May 1982, MMW, Munchener medizinische Wochenschrift,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
January 1984, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie,
C F Johnston, and Z R Desai, and J E Ardill, and J M Bridges, and K D Buchanan
September 1980, Acta physiologica Scandinavica,
Copied contents to your clipboard!